Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity
- PMID: 20732941
- PMCID: PMC2932835
- DOI: 10.1542/peds.2010-0098
Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity
Abstract
Objective: We evaluated the setting of published studies conducted under the US Pediatric Exclusivity Provision, which provides economic incentives to pharmaceutical companies to conduct drug studies with children.
Methods: Published studies containing the main results of trials conducted in 1998-2007 under the Pediatric Exclusivity Provision were included. Data were extracted from each study and described, including the therapeutic area of drug studied, number of patients enrolled, number of sites, and location where the study was conducted, if reported.
Results: Overall, 174 trials were included (sample size: 8-27 065 patients); 9% did not report any information regarding the location or number of sites where the study was conducted. Of trials that did report such information, 65% were conducted in >or=1 country outside the United States, and 11% did not include any sites in the United States. Fifty-four countries were represented, and 38% of trials enrolled patients in >or=1 site located in a developing/transition country, including more than one-third of infectious disease, cardiovascular, and allergy/immunology trials.
Conclusions: The majority of published pediatric trials conducted under the Pediatric Exclusivity Provision included sites outside the United States, and more than one-third of trials enrolled patients in developing/transition countries.
Figures
Comment in
-
Globalized pediatric research.Pediatrics. 2011 Jan;127(1):e251-2; author reply e253-4. doi: 10.1542/peds.2010-3381. Pediatrics. 2011. PMID: 21196575 No abstract available.
-
The globalization of pediatric trials: should we be worried?Pediatrics. 2011 Jan;127(1):e252-3; author reply e253-4. doi: 10.1542/peds.2010-3381A. Pediatrics. 2011. PMID: 21196576 Free PMC article. No abstract available.
References
-
- Summary of the Annual Review of Developments in Globalization and Regional Integration in the Countries of the ESCWA Region by the United Nations Economic and Social Commission for Western Asia. [Accessed January 5, 2010]. Available at: http://www.escwa.un.org/information/publications/edit/upload/grid-02-2.pdf.
-
- Glickman SW, McHutchinson JG, Peterson ED, et al. Ethical and Scientific Implications of the Globalization of Clinical Research. N Engl J Med. 2009;360:816–23. - PubMed
-
- The Pediatric Exclusivity Provision, January 2001 Status Report to Congress. [Accessed January 5, 2010]. Available at www.fda.gov/cder/pediatric.
-
- Best Pharmaceuticals for Children Act. [Accessed January 5, 2010]. Available at: www.fda.gov/cder/pediatric.
Publication types
MeSH terms
Grants and funding
- HHSN267200700051C/HD/NICHD NIH HHS/United States
- R01 HD057956/HD/NICHD NIH HHS/United States
- KL2 RR024127/RR/NCRR NIH HHS/United States
- 1R01HD057956-02/HD/NICHD NIH HHS/United States
- HHSN267 200700051C/PHS HHS/United States
- 1K24HD058735-01/HD/NICHD NIH HHS/United States
- R01 FD003519/FD/FDA HHS/United States
- 1R01FD003519-01/FD/FDA HHS/United States
- K23 HD060040/HD/NICHD NIH HHS/United States
- K24 HD058735/HD/NICHD NIH HHS/United States
- HHSN267200700051C/DK/NIDDK NIH HHS/United States
- U10 HD045962/HD/NICHD NIH HHS/United States
- 1K23HD060040-01/HD/NICHD NIH HHS/United States
- 1U10-HD45962-06/HD/NICHD NIH HHS/United States
